Health

CVS Selling EpiPen's Competitor Product at One Sixth of the Current Price

0 531

In September of 2016 the medical community, and the United States congress, were appalled when healthcare company Mylan Inc. announced a 500% price increase (now currently at a cost of $608 dollars) for a two-pack of allergy attack saving EpiPens. The free market once again comes to the rescue as CVS has just announced it is selling a generic version of the drug at a sixth of the price.

Continue Reading

Recommended Reading


The greatest dangers to liberty lurk in the insidious encroachment by men of zeal, well meaning but without understanding.

- Justice Louis Brandeis